Rebecca Shattuck-Brandt

2PUBLICATIONS
7CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 03, 2020
Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition.

Rebecca L Shattuck-Brandt, Sheau-Chiann Chen, Emily Murray

|Aug 16, 2019
MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21.

Anna E Vilgelm, Nabil Saleh, Rebecca Shattuck-Brandt

Pageof 1